Pride and Pioneers

Pride and pioneers NRW's behemoth chemical companies generate about one third of the German chemical industry's global sales. For biotechnology, this dominance can be both a blessing and a curse. By Ludger Wess The production of 200 liter batches of resin used in Qiagen's spin columns for the isolation of nucleic acids. © Juergen Bindrim For more than a century, the state of North Rhine-Westphalia (NRW) has been the heartland o

Written byLudger Wess
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

By Ludger Wess

For more than a century, the state of North Rhine-Westphalia (NRW) has been the heartland of Germany's pharma and chemistry industry. Today, while the chemical industry is still strong, Germany is no longer the pharmacy of the world although NRW still houses a significant portion of companies active in pharmaceuticals. This amounts to about 150 companies, mostly small and medium-sized enterprises; only four have more than 1,000 employees. Most global pharmaceutical companies are represented in NRW—by subsidiaries, production facilities, or distribution centers—a reflection of the highly qualified employee base and the size of the market. For example, the German headquarters of Japanese company Takeda Pharma is located in Aachen, of Wyeth Pharma in Münster, and of Janssen-Cilag (Johnson & Johnson) in Neuss. Other companies with a presence in the state include Bayer Schering Pharma and Schwarz Pharma (UCB).

The presence of big corporations has impacted the state's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform